SCHEMBL28486758

SCHEMBL28486758

Oc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 1.00
MAPK13 O15264 14/20 1.00
MAPK12 P53778 14/20 1.00
MAPK11 Q15759 14/20 1.00
RAF1 P04049 9/20 1.00
BRAF P15056 5/20 1.00
MAPK9 P45984 2/20 0.82
GCGR P47871 6/20 0.77
MAPT P10636 3/20 0.77
BRDT Q58F21 2/20 0.77
ALOX5 P09917 2/20 0.77
CSNK1D P48730 2/20 0.77
CSNK1E P49674 2/20 0.77
KDM4E B2RXH2 1/20 0.77
CIT O14578 1/20 0.77
GAK O14976 1/20 0.77
RIPK2 O43353 1/20 0.77
BRD4 O60885 1/20 0.77
GMNN O75496 1/20 0.77
PRKD3 O94806 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6469877 1.00 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL252964 0.92 MAPK13 (0.85) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL15401173 0.92 MAPK13 (0.85) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL9619859 0.92 MAPK13 (0.85) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL18292488 0.92 MAPK13 (0.85) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL5307418 0.92 MAPK13 (0.85) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL12561713 0.91 MAPK13 (0.83) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL31255400 0.91 MAPK13 (0.83) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL7228717 0.91 MAPK13 (1.00) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL2949385 0.91 MAPK13 (1.00) MAPK14MAPK13MAPK12MAPK11RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117562905-A Maintenance of immune response during chemotherapy regimen G1治疗公司 2024-02-20 CN disclosed
CN-117530948-A Maintenance of immune response during chemotherapy regimen G1治疗公司 2024-02-09 CN disclosed
CN-111837146-A Excellent dosage regimen for G1T38 G1治疗公司 2020-10-27 CN disclosed